Brokerages expect Sabra Health Care REIT Inc (NASDAQ:SBRA) to report $0.61 earnings per share (EPS) for the current quarter, according to Zacks. Four analysts have provided estimates for Sabra Health Care REIT’s earnings. The lowest EPS estimate is $0.59 and the highest is $0.63. Sabra Health Care REIT posted earnings of $0.53 per share during the same quarter last year, which suggests a positive year-over-year growth rate of 15.1%. The business is expected to issue its next earnings report on Monday, May 14th.
According to Zacks, analysts expect that Sabra Health Care REIT will report full-year earnings of $2.50 per share for the current fiscal year, with EPS estimates ranging from $2.48 to $2.53. For the next fiscal year, analysts expect that the firm will post earnings of $2.55 per share, with EPS estimates ranging from $2.49 to $2.64. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of research analysts that follow Sabra Health Care REIT.
Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Wednesday, February 21st. The real estate investment trust reported $0.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.30 by $0.27. The business had revenue of $166.47 million during the quarter, compared to the consensus estimate of $158.82 million. Sabra Health Care REIT had a net margin of 39.04% and a return on equity of 7.19%.
SBRA has been the subject of a number of research reports. Zacks Investment Research lowered shares of Sabra Health Care REIT from a “hold” rating to a “sell” rating in a research report on Wednesday, January 10th. Bank of America upgraded shares of Sabra Health Care REIT from an “underperform” rating to a “neutral” rating and set a $20.00 target price for the company in a research report on Monday, March 26th. Stifel Nicolaus reiterated a “hold” rating and set a $21.00 target price (down previously from $22.00) on shares of Sabra Health Care REIT in a research report on Thursday, February 22nd. Mizuho set a $18.00 target price on shares of Sabra Health Care REIT and gave the stock a “hold” rating in a research report on Friday, February 23rd. Finally, Wells Fargo cut their target price on shares of Sabra Health Care REIT from $24.00 to $19.00 and set a “market perform” rating for the company in a research report on Tuesday, March 20th. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $23.45.
Hedge funds have recently added to or reduced their stakes in the company. Ffcm LLC boosted its position in shares of Sabra Health Care REIT by 1,297.4% in the fourth quarter. Ffcm LLC now owns 5,897 shares of the real estate investment trust’s stock valued at $112,000 after acquiring an additional 5,475 shares during the period. BB&T Securities LLC bought a new position in shares of Sabra Health Care REIT in the third quarter valued at approximately $200,000. MANA Advisors LLC bought a new position in shares of Sabra Health Care REIT in the fourth quarter valued at approximately $193,000. Atria Investments LLC bought a new position in shares of Sabra Health Care REIT in the fourth quarter valued at approximately $208,000. Finally, FNY Partners Fund LP boosted its position in shares of Sabra Health Care REIT by 64.8% in the fourth quarter. FNY Partners Fund LP now owns 11,700 shares of the real estate investment trust’s stock valued at $219,000 after acquiring an additional 4,600 shares during the period. Institutional investors own 88.88% of the company’s stock.
NASDAQ:SBRA traded up $0.01 on Tuesday, reaching $17.60. 1,607,568 shares of the company’s stock were exchanged, compared to its average volume of 1,974,679. The company has a quick ratio of 6.85, a current ratio of 6.85 and a debt-to-equity ratio of 0.99. The firm has a market capitalization of $3,155.13, a PE ratio of 7.24, a P/E/G ratio of 2.32 and a beta of 0.65. Sabra Health Care REIT has a 52 week low of $15.77 and a 52 week high of $29.10.
WARNING: This piece of content was originally posted by Macon Daily and is the sole property of of Macon Daily. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this piece of content can be accessed at https://macondaily.com/2018/04/17/zacks-analysts-anticipate-sabra-health-care-reit-inc-sbra-to-announce-0-61-eps-updated.html.
Sabra Health Care REIT Company Profile
Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
Get a free copy of the Zacks research report on Sabra Health Care REIT (SBRA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.